August 11, 2025

Alkermes plc (ALKS) Stock Analysis: Exploring a 55% Potential Upside with Robust Analyst Confidence

Alkermes plc (NASDAQ: ALKS), a prominent player in the healthcare sector, particularly within the drug manufacturers’ specialty and generic industries, presents a compelling investment case for those eyeing the biopharmaceutical..

ICON plc (ICLR) Stock Analysis: Unveiling a 38.1% Upside Opportunity in Healthcare Research

Investors seeking opportunities in the healthcare sector may want to take a closer look at ICON plc (NASDAQ: ICLR), a key player in the diagnostics and research industry. Headquartered in..

United Therapeutics Corporation (UTHR) Stock Analysis: Exploring a 24.98% Upside Potential

United Therapeutics Corporation (NASDAQ: UTHR), a heavyweight in the healthcare sector, is firmly positioned in the drug manufacturing industry with a specialization in both specialty and generic medications. With a..

Glaukos Corporation (GKOS) Stock Analysis: A 44.67% Potential Upside Amidst Healthcare Innovations

Glaukos Corporation (NYSE: GKOS) is making waves in the healthcare sector with its innovative solutions for treating eye diseases. The company, headquartered in Aliso Viejo, California, specializes in ophthalmic pharmaceuticals..

Chemed Corp (CHE) Stock Analysis: A Lucrative 30% Upside Awaits Investors

Chemed Corp (NYSE: CHE) is a compelling investment opportunity in the healthcare sector, primarily due to its potential upside of 30.30%, as indicated by analyst ratings. With a market cap..

Bausch + Lomb (BLCO): Investor Outlook on a Healthcare Stalwart with 11% Potential Upside

Bausch + Lomb Corporation (BLCO) stands as a historic pillar in the healthcare sector, particularly within the medical instruments and supplies industry. With its roots tracing back to 1853, this..

Axsome Therapeutics, Inc. (AXSM): Investor Outlook with a Potential 68.84% Upside

Investors looking for a compelling opportunity in the healthcare sector may find Axsome Therapeutics, Inc. (NASDAQ: AXSM) an intriguing prospect. As a biopharmaceutical company dedicated to advancing treatments for central..

Alnylam Pharmaceuticals, Inc. (ALNY) Stock Analysis: Navigating Growth Amidst Uncertain Valuations

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) stands as a formidable player within the biotechnology sector, a space renowned for its innovation and volatility. With a current market capitalization of approximately $57.53..

Revvity, Inc. (RVTY) Stock Analysis: Healthcare Innovator with a 34.51% Upside Potential

Revvity, Inc. (NYSE: RVTY), a prominent player in the healthcare sector, is currently spotlighted for its remarkable growth potential. With a market capitalization of $10.08 billion, this Waltham, Massachusetts-based company..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: A Robust Pharmaceutical Play with 8.73% Upside Potential

Dr. Reddy’s Laboratories Ltd (NYSE: RDY), a key player in the global pharmaceutical landscape, has captured investor attention with its diversified business model and consistent revenue growth. Based in Hyderabad,..

Insulet Corporation (PODD) Stock Analysis: Unpacking a 14.59% Potential Upside Amid Strong Analyst Ratings

Investors eyeing Insulet Corporation (NASDAQ: PODD) are witnessing a promising opportunity in the healthcare sector, particularly within the medical devices industry. With a market capitalization of $21.62 billion, Insulet is..

Cytokinetics, Inc. (CYTK) Stock Analysis: Unveiling a Potential 110% Upside in Biotech

Cytokinetics, Incorporated (NASDAQ: CYTK), a prominent player in the biotechnology sector, is drawing investor attention with its compelling potential upside of 110.93%. Based in South San Francisco, California, this late-stage..

Rhythm Pharmaceuticals, Inc. (RYTM) Investor Outlook: 22% Upside Potential and Strong Buy Ratings

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is capturing attention in the biotech sector with its promising pipeline focused on rare neuroendocrine diseases. As a commercial-stage biopharmaceutical company, Rhythm Pharmaceuticals is strategically..

Option Care Health, Inc. (OPCH) Stock Analysis: A Strong Buy with 37.51% Potential Upside

Option Care Health, Inc. (NASDAQ: OPCH), a leader in home and alternate site infusion services, has captured investor attention with its significant growth potential and robust analyst ratings. Based in..

Avidity Biosciences, Inc. (RNA) Stock Analysis: Exploring a 44.50% Potential Upside in RNA Therapeutics

Avidity Biosciences, Inc. (NASDAQ: RNA) is at the forefront of a promising frontier in the biotechnology sector, leveraging innovative RNA therapeutics to address previously untreatable diseases. Headquartered in San Diego,..

Inspire Medical Systems (INSP): Analyst Consensus Points to 83.85% Potential Upside in Medical Device Innovator

Inspire Medical Systems, Inc. (NASDAQ: INSP) is capturing investor attention with its innovative approach to treating obstructive sleep apnea (OSA). The company, headquartered in Golden Valley, Minnesota, has carved a..

Universal Health Services, Inc. (UHS) Stock Analysis: A Deep Dive into Growth Potential and Analyst Ratings

Universal Health Services, Inc. (NYSE: UHS) stands as a formidable player in the healthcare sector, specifically within the Medical Care Facilities industry. Headquartered in King of Prussia, Pennsylvania, UHS operates..

Baxter International Inc. (BAX) Stock Analysis: Navigating a 23.92% Potential Upside Amidst Healthcare Sector Dynamics

Baxter International Inc. (NYSE: BAX) remains a focal point for investors seeking opportunities within the healthcare sector, particularly in the medical instruments and supplies industry. With a market capitalization of..

CVS Health Corporation (CVS) Stock Analysis: Unlocking a 22.62% Potential Upside in Healthcare

CVS Health Corporation (NYSE: CVS), a dominant player in the healthcare sector, has been a focal point for investors seeking both value and growth. With a market capitalization of $83.13..

RadNet, Inc. (RDNT) Growth Potential: Analyst Ratings Signal 34% Upside

For investors seeking opportunities in the healthcare sector, RadNet, Inc. (NASDAQ: RDNT) presents a compelling case. As a prominent player in the diagnostics and research industry, RadNet operates a robust..

Search

Funds

August 11, 2025

Search

Funds

August 11, 2025

FTSE 100

Funds